The co-antibody therapy JNJ-4804 -- a fixed-dose combination of guselkumab (Tremfya) and golimumab (Simponi) -- showed clinically meaningful efficacy exceeding that of either drug alone in patients ...
Everyday Health on MSN
UTIs in older adults: What you need to know
UTIs occur more frequently in older adults, and particularly in older women. Learn how to spot the signs and symptoms of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results